BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2915239)

  • 1. Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer.
    Eapen L; Stewart D; Danjoux C; Genest P; Futter N; Moors D; Irvine A; Crook J; Aitken S; Gerig L
    J Clin Oncol; 1989 Feb; 7(2):230-5. PubMed ID: 2915239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraarterial infusion of cisplatin with and without preoperative concurrent radiation for urinary bladder cancer: a preliminary report.
    Monzen Y; Mori H; Matsumoto S; Takaki H; Yoshida S; Wakisaka M; Ueda S; Mizoguchi H; Ogata J; Kato Y
    Radiat Med; 1995; 13(3):149-52. PubMed ID: 7569009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of combined therapy using balloon-occluded arterial infusion of cisplatin and hemodialysis with concurrent radiation for locally invasive bladder cancer.
    Azuma H; Kotake Y; Yamamoto K; Sakamoto T; Kiyama S; Ubai T; Inamoto T; Takahara K; Matsuki M; Segawa N; Shibahara N; Katsuoka Y
    Am J Clin Oncol; 2008 Feb; 31(1):11-21. PubMed ID: 18376222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
    Azuma H; Yamamoto K; Inamoto T; Ibuki N; Kotake Y; Sakamoto T; Kiyama S; Ubai T; Takahara K; Segawa N; Narumi Y; Katsuoka Y
    Am J Clin Oncol; 2009 Dec; 32(6):592-606. PubMed ID: 19593084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
    Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W
    J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined intraarterial cisplatin infusion and radiation therapy for invasive bladder cancer.
    Mizoguchi H; Nomura Y; Terada K; Nakagawa M; Ogata J
    Int J Urol; 1995 Mar; 2(1):17-23. PubMed ID: 7614405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12.
    Tester W; Porter A; Asbell S; Coughlin C; Heaney J; Krall J; Martz K; Venner P; Hammond E
    Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):783-90. PubMed ID: 8478228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results of bladder-preserving therapy with definitive radiotherapy and intraarterial infusion of chemotherapy.
    Tsujii H; Akaza H; Ohtani M; Miyanaga N; Shimazoi T; Uchida K; Koiso K; Tsuji H; Okumura T; Ohara K
    Strahlenther Onkol; 1994 Sep; 170(9):531-7. PubMed ID: 7940124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The combined treatment of locally disseminated bladder cancer].
    Kariakin OB; Mardynskiĭ IuS; Grishin GN; Sakharova OV; Tepliakova IuV
    Urol Nefrol (Mosk); 1996; (1):17-9. PubMed ID: 8659033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow up of patients with invasive bladder carcinoma receiving combined cisplatin-based intra-arterial chemotherapy and radiotherapy.
    Mori K; Nomata K; Noguchi M; Eguchi J; Hayashi N; Kanetake H
    Int J Urol; 2007 Jul; 14(7):591-4. PubMed ID: 17645599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients].
    Serretta V; Vasile P; Falletta V; Piazza F; Pavone C; Pavone-Macaluso M
    Arch Ital Urol Androl; 1998 Jun; 70(3 Suppl):37-40. PubMed ID: 9707769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.
    Coppin CM; Gospodarowicz MK; James K; Tannock IF; Zee B; Carson J; Pater J; Sullivan LD
    J Clin Oncol; 1996 Nov; 14(11):2901-7. PubMed ID: 8918486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
    Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy and concurrent daily intra-arterial infusion of low-dose cisplatin following alteration of pelvic blood flow for invasive bladder cancer: a preliminary report.
    Akimoto T; Matsumoto M; Mashimo T; Mitsuhashi N; Niibe H
    Anticancer Res; 1998; 18(5B):3731-5. PubMed ID: 9854485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery.
    Shipley WU; Prout GR; Einstein AB; Coombs LJ; Wajsman Z; Soloway MS; Englander L; Barton BA; Hafermann MD
    JAMA; 1987 Aug; 258(7):931-5. PubMed ID: 3613023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
    Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
    Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder preservation by combined modality therapy for invasive bladder cancer.
    Kachnic LA; Kaufman DS; Heney NM; Althausen AF; Griffin PP; Zietman AL; Shipley WU
    J Clin Oncol; 1997 Mar; 15(3):1022-9. PubMed ID: 9060542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy.
    Fung CY; Shipley WU; Young RH; Griffin PP; Convery KM; Kaufman DS; Althausen AF; Heney NM; Prout GR
    J Clin Oncol; 1991 Sep; 9(9):1533-42. PubMed ID: 1875217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.